Rational dosing of azathioprine and 6-mercaptopurine

被引:113
作者
Sandborn, WJ [1 ]
机构
[1] Mayo Clin & Mayo Fdn, Div Gastroenterol & Hepatol, Inflammatory Bowel Dis Clin, Rochester, MN 55905 USA
关键词
D O I
10.1136/gut.48.5.591
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:591 / 592
页数:2
相关论文
共 13 条
  • [1] Thiopurine methyltransferase genotype predicts therapy-limiting severe toxicity from azathioprine
    Black, AJ
    McLeod, HL
    Capell, HA
    Powrie, RH
    Matowe, LK
    Pritchard, SC
    Collie-Duguid, ESR
    Reid, DM
    [J]. ANNALS OF INTERNAL MEDICINE, 1998, 129 (09) : 716 - 718
  • [2] Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy
    Colombel, JF
    Ferrari, N
    Debuysere, H
    Marteau, P
    Gendre, JP
    Bonaz, B
    Soulé, JC
    Modgliani, R
    Touze, Y
    Catala, P
    Libersa, C
    Broly, F
    [J]. GASTROENTEROLOGY, 2000, 118 (06) : 1025 - 1030
  • [3] Utilisation of erythrocyte 6-thioguanine metabolite levels to optimise azathioprine therapy in patients with inflammatory bowel disease
    Cuffari, C
    Hunt, S
    Bayless, T
    [J]. GUT, 2001, 48 (05) : 642 - 646
  • [4] 6-Mercaptopurine metabolism in Crohn's disease: Correlation with efficacy and toxicity
    Cuffari, C
    Theoret, Y
    Latour, S
    Seidman, G
    [J]. GUT, 1996, 39 (03) : 401 - 406
  • [5] Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease
    Dubinsky, MC
    Lamothe, S
    Yang, HY
    Targan, SR
    Sinnett, D
    Théorêt, Y
    Seidman, EG
    [J]. GASTROENTEROLOGY, 2000, 118 (04) : 705 - 713
  • [6] Thioguanine (6-TG): A therapeutic alternative in a subgroup of IBD patients failing 6-mercaptopurine (6-MP)
    Dubinsky, MC
    Hassard, PV
    Abreu, MT
    Kam, LY
    Seidman, EG
    Targan, SR
    Vasiliauskas, EA
    [J]. GASTROENTEROLOGY, 2000, 118 (04) : A891 - A891
  • [7] 6-mercaptopurine (6MP) metabolite levels in children with IBD: Lack of correlation of 6-thioguanine (6TG) levels with clinical response.
    Gupta, P
    Gokhale, R
    Kirschner, BS
    [J]. GASTROENTEROLOGY, 2000, 118 (04) : A787 - A787
  • [8] THE CLINICAL-PHARMACOLOGY OF 6-MERCAPTOPURINE
    LENNARD, L
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1992, 43 (04) : 329 - 339
  • [9] Cross-sectional study of ibd patients taking azathioprine (AZA) or 6 mercaptopurine (6-MP): Lack of correlation between disease activity and 6 thioguanine nucleotide (6TGN) concentration.
    Lowry, PW
    Franklin, CL
    Weaver, AL
    Pike, MG
    Mays, DC
    Tremaine, WJ
    Lipsky, JJ
    Sandborn, WJ
    [J]. GASTROENTEROLOGY, 2000, 118 (04) : A788 - A788
  • [10] AZATHIOPRINE AND 6-MERCAPTOPURINE IN CROHN DISEASE - A METAANALYSIS
    PEARSON, DC
    MAY, GR
    FICK, GH
    SUTHERLAND, LR
    [J]. ANNALS OF INTERNAL MEDICINE, 1995, 123 (02) : 132 - 142